PANBIO™ COVID-19 Ag RDT (Nasopharyngeal)

Panbio™ COVID-19 Ag Rapid Test Device supports COVID19 testing in both symptomatic and asymptomatic patients



PanBio COVID19 Ag is an in vitro RDT for the qualitative detection of SARS-CoV-antigen (Ag) in human nasalpharyngeal specimens.

High performance rapid test enables immediate treatment or isolation measures to minimize transmission.

Accessible, easy-to-deploy, large-scale testing helps contain the virus spread.


There are no reviews yet.

Be the first to review “PANBIO™ COVID-19 Ag RDT (Nasopharyngeal)”

Your email address will not be published. Required fields are marked *